By Matthew Perlman ( November 2, 2015, 1:26 PM EST) -- Irish drugmaker Shire PLC on Monday said that it has agreed to buy Dyax Corp. for $5.9 billion in cash, in a deal guided by Ropes & Gray LLP, as Shire beefs up its portfolio of rare disease treatments and continues to pursue an unsolicited $30 billion offer for Baxalta Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.